Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET

by T. Lee Collier PhD, Kevin P. Maresca PhD, Marc D. Normandin PhD, Paul Richardson PhD, Timothy J. McCarthy PhD, Steven H. Liang PhD, Rikki N. Waterhouse PhD, Neil Vasdev PhD
Published 2017-10-01